Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines.

Morlando S, Cox AWI, Thite AM, Aidoo R, Wilkinson J, Topham CH, Di Leva G

Open source

DOI
10.1007/s12672-026-04717-7
Published
2026 Feb 23
Container
Discover oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12672-026-04717-7,
  title = {Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines.},
  author = {Morlando S and Cox AWI and Thite AM and Aidoo R and Wilkinson J and Topham CH and Di Leva G},
  year = {2026},
  journal = {Discover oncology},
  doi = {10.1007/s12672-026-04717-7},
  url = {https://doi.org/10.1007/s12672-026-04717-7}
}

RIS

TY  - JOUR
TI  - Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines.
AU  - Morlando S
AU  - Cox AWI
AU  - Thite AM
AU  - Aidoo R
AU  - Wilkinson J
AU  - Topham CH
AU  - Di Leva G
PY  - 2026
JO  - Discover oncology
DO  - 10.1007/s12672-026-04717-7
UR  - https://doi.org/10.1007/s12672-026-04717-7
ER  - 

APA

S, M., AWI, C., AM, T., R, A., J, W., CH, T., & G, D. L. (2026). Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines.. Discover oncology. https://doi.org/10.1007/s12672-026-04717-7

Source records